Latest News for: wuxi apptec
Edit
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key Players - Porton Advanced, WuXi AppTec, Thermo Fisher Scientific, Charles River Labs, Lonza and More - ResearchAndMarkets.com
Pharmiweb 02 Dec 2025
DUBLIN--(BUSINESS WIRE)--The "Middle East Cell and Gene Therapy CDMO Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering ... Porton Pharma Solutions, Ltd. (Porton Advanced) WuXi AppTec Thermo Fisher Scientific, Inc ... Middle East ... No.
Edit
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry (Frost & Sullivan)
Public Technologies 21 Nov 2025
WuXi AppTec excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with precision and scalability ... Ge Li, Chairman and CEO of WuXi AppTec ... About WuXi AppTec.
Edit
The Pilot News
20 Nov 2025
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Award in the ...
19, 2025 /PRNewswire/ -- WuXi AppTec, a leading global ...
Edit
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the ...
Canada Newswire 20 Nov 2025
WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines for patients ... Ge Li, Chairman and CEO of WuXi AppTec.
Edit
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Award in the CRDMO Industry
PR Newswire 20 Nov 2025
This marks the ninth consecutive year that WuXi AppTec has received this distinguished honor, underscoring the company's ongoing achievements in enabling innovation and operational excellence for its customers ... Ge Li, Chairman and CEO of WuXi AppTec.
Edit
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry
PR Newswire 20 Nov 2025
WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines for patients ... Ge Li, Chairman and CEO of WuXi AppTec.
Edit
NEOM and WuXi AppTec sign strategic MoU to advance Saudi Arabia’s biotech sector
Eye Of Riyadh 29 Oct 2025
By aligning world-class expertise with national goals, the partnership between NEOM and WuXi AppTec aims to create the conditions for advanced manufacturing and sectoral growth that will serve both regional and global markets.
Edit
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
PR Newswire 28 Oct 2025
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoU with NEOM. WuXi AppTec and NEOM have agreed to collaborate to explore the localization of pharmaceutical research, development and manufacturing in Saudi Arabia.
Edit
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for ...
Bennington Banner 27 Oct 2025
Edit
WuXi AppTec Unveils Modernized Logo, Reflecting Continued Evolution as a Global Healthcare Partner (WuXi AppTec Co Ltd)
Public Technologies 26 Oct 2025
These triadic shapes unite seamlessly into three swift slashes, forming the capital letters "W" and "X" of WuXi AppTec ... WuXi AppTec Co.
Edit
WuXi AppTec Signs Definitive Agreement to Sell China-based Clinical Research Services Business to Hillhouse (WuXi AppTec Co Ltd)
Public Technologies 26 Oct 2025
[Shanghai, October 26, 2025] - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...
Edit
WuXi AppTec Q3 profit jumps, to sell two research arms to Hillhouse for 2.8 billion yuan
Hong Kong Standard 26 Oct 2025
Edit
WuXi AppTec 2025 Third Quarterly Results Presentation (WuXi AppTec Co Ltd)
Public Technologies 26 Oct 2025
Edit
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY; Further Raises 2025 Full-year Guidance (WuXi AppTec Co Ltd)
Public Technologies 26 Oct 2025
Ge Li, Chairman and CEO of WuXi AppTec, said, "Reflecting robust customer demand and the strength of our unique CRDMO business model, WuXi AppTec delivered strong double-digit growth in revenue, ...
Edit
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance (WuXi AppTec Co Ltd)
Public Technologies 26 Oct 2025
Ge Li, Chairman and CEO of WuXi AppTec, said, "Reflecting robust customer demand and the strength of our unique CRDMO business model, WuXi AppTec delivered strong double-digit growth in revenue, ...
- 1
- 2
- Next page »